merger
First 3D Printing SPAC Deal of 2023: Sakuu Ready to Go Public with Battery 3D Printing
Sakuu, a California-based 3D printed battery cell manufacturer, is slated to go public via a merger with Plum Acquisition Corp. I (NASDAQ: PLMI), a blank check company led by former…
UltiMaker Announces MakerBot SKETCH Large 3D Printer for the Classroom
Today, UltiMaker announced its latest 3D printing solution for the classroom: the MakerBot SKETCH Large. UltiMaker, the Utrecht-based leader among desktop 3D printer original equipment manufacturers (OEMs), is the product…
3D Printing News Briefs, August 24, 2022: New Hires, Metal 3D Printers, PCBs, & More
We’re starting off with business in 3D Printing News Briefs, as both Evolve and PostProcess Technologies have added new executives to their teams, and Multiphoton Optics is now a Heidelberg…
Essentium to Go Public via SPAC, Announces Metal 3D Printing Development
Essentium is the latest firm in the 3D printing industry to announce a merger with a special purpose acquisition company (SPAC) to achieve a public listing. The Austin-based startup has…
Shapeways CEO Greg Kress Discusses the Upcoming SPAC Merger
On April 28, 2021, 3D printing service bureau Shapeways announced that it was going public via merger with special purpose acquisition company (SPAC) Galileo Acquisition Corp. I had a chance…
Rocket 3D Printing Gets IPO Boost via Rocket Lab SPAC Merger
3D printing is becoming a hot commodity once more as numerous startups make their way to the stock market via mergers with special purpose acquisition companies (SPACs). The latest is…
3D Printing Startup Markforged to Go Public via SPAC Merger
Markforged, a leader in industrial 3D printing, prepares to go public after a merger deal with blank-check company one (NYSE: AONE), a $200 million special purpose acquisition company (SPAC) backed…
Organovo’s Merger Deal with Tarveda Falls Through, for Now
It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…
Former CEO of Organovo Urges Stockholders Against Merger with Tarveda
Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…
